DK1566173T3 - Farmaceutisk sammensætning til oral anvendelse og fremgangsmåde til fremstilling deraf - Google Patents
Farmaceutisk sammensætning til oral anvendelse og fremgangsmåde til fremstilling derafInfo
- Publication number
- DK1566173T3 DK1566173T3 DK04003906T DK04003906T DK1566173T3 DK 1566173 T3 DK1566173 T3 DK 1566173T3 DK 04003906 T DK04003906 T DK 04003906T DK 04003906 T DK04003906 T DK 04003906T DK 1566173 T3 DK1566173 T3 DK 1566173T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceutical composition
- preparation
- oral use
- composition
- bet
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229940124339 anthelmintic agent Drugs 0.000 abstract 1
- 239000000921 anthelmintic agent Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04003906A EP1566173B1 (fr) | 2004-02-20 | 2004-02-20 | Composition pharmaceutique orale et procédé de preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1566173T3 true DK1566173T3 (da) | 2006-12-27 |
Family
ID=34707350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04003906T DK1566173T3 (da) | 2004-02-20 | 2004-02-20 | Farmaceutisk sammensætning til oral anvendelse og fremgangsmåde til fremstilling deraf |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7767228B2 (fr) |
| EP (2) | EP1566173B1 (fr) |
| JP (1) | JP4800225B2 (fr) |
| AT (1) | ATE336230T1 (fr) |
| AU (1) | AU2005215108B2 (fr) |
| BR (1) | BRPI0507848A (fr) |
| CA (1) | CA2554640C (fr) |
| DE (1) | DE602004001969T2 (fr) |
| DK (1) | DK1566173T3 (fr) |
| ES (1) | ES2271714T3 (fr) |
| NO (1) | NO20064240L (fr) |
| PT (1) | PT1566173E (fr) |
| RU (1) | RU2342936C2 (fr) |
| SI (1) | SI1566173T1 (fr) |
| WO (1) | WO2005079759A2 (fr) |
| ZA (1) | ZA200606554B (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8106000B2 (en) * | 2005-05-18 | 2012-01-31 | Da Volterra | Colonic delivery of adsorbents |
| US8048413B2 (en) | 2006-05-17 | 2011-11-01 | Helene Huguet | Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules |
| UY31410A1 (es) * | 2007-10-30 | 2009-05-29 | Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado | |
| JP2010106007A (ja) * | 2008-08-14 | 2010-05-13 | Sony Corp | 薬剤徐放剤、吸着剤、機能性食品、マスク及び吸着シート |
| JP5860284B2 (ja) * | 2008-12-05 | 2016-02-16 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ | 針状の活性物質を含む押出物 |
| HU231017B1 (hu) | 2012-05-08 | 2019-11-28 | LAVET Gyógyszeripari Kft. | Praziquantel tartalmú ízfedett formulációk |
| RU2514056C2 (ru) * | 2012-08-21 | 2014-04-27 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова Министерства сельского хозяйства Российской Федерации | Способ инкапсуляции фенбендазола |
| JP6472341B2 (ja) * | 2015-06-26 | 2019-02-20 | 株式会社トーヨー技術研究所 | 固形状の魚類用経口投与薬剤、当該薬剤を含む養魚用飼料、および当該薬剤を魚に投与する方法 |
| CA3191671A1 (fr) | 2020-09-04 | 2022-03-10 | Elanco Us Inc. | Formulations palatables |
| CN117881425A (zh) * | 2021-08-31 | 2024-04-12 | 株式会社东洋技术研究所 | 水栖动物用经口给药药剂 |
| CN117915955A (zh) * | 2021-08-31 | 2024-04-19 | 株式会社东洋技术研究所 | 水栖动物用经口给药药剂 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1879601A (en) * | 1926-03-13 | 1932-09-27 | Merck & Co Inc | Iodine composition |
| NL294490A (fr) * | 1962-06-25 | |||
| US3709833A (en) * | 1970-08-21 | 1973-01-09 | Owens Illinois Inc | Process for preparing high purity silicon oxide porous beads doped with small quantities of other oxides |
| US4581232A (en) * | 1983-07-20 | 1986-04-08 | Warner-Lambert Company | Magnesium trisilicate suitable for preparation of medicament adsorbates |
| SU1465052A1 (ru) * | 1985-06-10 | 1989-03-15 | Институт Зоологии Ан Казсср | Способ профилактики и лечени гельминтозов животных |
| US5013716A (en) * | 1988-10-28 | 1991-05-07 | Warner-Lambert Company | Unpleasant taste masking compositions and methods for preparing same |
| RU2034549C1 (ru) * | 1990-05-29 | 1995-05-10 | Научно-производственное малое предприятие "Аксис" | Антгельминтное средство для лечения нематодозов овец |
| JPH05238930A (ja) * | 1992-02-28 | 1993-09-17 | Eisai Co Ltd | 持続性薬剤 |
| RU2092155C1 (ru) * | 1993-06-22 | 1997-10-10 | Валентина Ивановна Ходак | Способ получения твердого лекарственного препарата для перорального введения |
| US5585115A (en) * | 1995-01-09 | 1996-12-17 | Edward H. Mendell Co., Inc. | Pharmaceutical excipient having improved compressability |
| IL116674A (en) * | 1995-01-09 | 2003-05-29 | Mendell Co Inc Edward | Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof |
| US5827497A (en) * | 1996-08-14 | 1998-10-27 | Mayo Foundation For Medical Education And Research | Charcoal-radionuclide agents for measurement of gastrointestinal transit |
| CN1158071C (zh) * | 1997-05-30 | 2004-07-21 | 渗透有限公司 | 多层渗透装置 |
| DE19726412A1 (de) * | 1997-06-21 | 1998-12-24 | Merck Patent Gmbh | Implantatmaterial mit einer Träger-Wirkstoff-Kombination |
| US6565885B1 (en) * | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
| JP3834732B2 (ja) * | 1998-08-05 | 2006-10-18 | 株式会社ロッテ | チューインガム |
| US6555139B2 (en) * | 1999-06-28 | 2003-04-29 | Wockhardt Europe Limited | Preparation of micron-size pharmaceutical particles by microfluidization |
| US6491949B2 (en) * | 2000-01-14 | 2002-12-10 | Osmotica Corp. | Osmotic device within an osmotic device |
| US6352721B1 (en) * | 2000-01-14 | 2002-03-05 | Osmotica Corp. | Combined diffusion/osmotic pumping drug delivery system |
| EP1362583A1 (fr) * | 2002-05-15 | 2003-11-19 | CUM Taste Masking AG | Procédé pour masquer le goût de substances par microencapsulation |
| US7001889B2 (en) * | 2002-06-21 | 2006-02-21 | Merial Limited | Anthelmintic oral homogeneous veterinary pastes |
| JP4603357B2 (ja) * | 2002-08-13 | 2010-12-22 | インターベツト・インターナシヨナル・ベー・ベー | 添加剤をデリバリーするための組成物及び方法 |
| WO2004040679A1 (fr) * | 2002-10-31 | 2004-05-13 | Matsushita Electric Industrial Co., Ltd. | Electrode poreuse et dispositif electrochimique reposant sur l'utilisation de ladite electrode |
-
2004
- 2004-02-20 PT PT04003906T patent/PT1566173E/pt unknown
- 2004-02-20 DK DK04003906T patent/DK1566173T3/da active
- 2004-02-20 DE DE602004001969T patent/DE602004001969T2/de not_active Expired - Lifetime
- 2004-02-20 SI SI200430070T patent/SI1566173T1/sl unknown
- 2004-02-20 EP EP04003906A patent/EP1566173B1/fr not_active Expired - Lifetime
- 2004-02-20 ES ES04003906T patent/ES2271714T3/es not_active Expired - Lifetime
- 2004-02-20 AT AT04003906T patent/ATE336230T1/de active
- 2004-03-05 US US10/794,310 patent/US7767228B2/en not_active Expired - Fee Related
-
2005
- 2005-02-09 ZA ZA200606554A patent/ZA200606554B/xx unknown
- 2005-02-09 BR BRPI0507848-2A patent/BRPI0507848A/pt not_active IP Right Cessation
- 2005-02-09 CA CA2554640A patent/CA2554640C/fr not_active Expired - Fee Related
- 2005-02-09 JP JP2006553492A patent/JP4800225B2/ja not_active Expired - Fee Related
- 2005-02-09 AU AU2005215108A patent/AU2005215108B2/en not_active Ceased
- 2005-02-09 EP EP05701388A patent/EP1715850A2/fr not_active Withdrawn
- 2005-02-09 WO PCT/EP2005/001297 patent/WO2005079759A2/fr not_active Ceased
- 2005-02-09 RU RU2006133543/15A patent/RU2342936C2/ru active
-
2006
- 2006-09-19 NO NO20064240A patent/NO20064240L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2342936C2 (ru) | 2009-01-10 |
| US7767228B2 (en) | 2010-08-03 |
| EP1715850A2 (fr) | 2006-11-02 |
| NO20064240L (no) | 2006-11-20 |
| CA2554640A1 (fr) | 2005-09-01 |
| WO2005079759A2 (fr) | 2005-09-01 |
| AU2005215108A1 (en) | 2005-09-01 |
| WO2005079759A3 (fr) | 2006-06-15 |
| BRPI0507848A (pt) | 2007-07-10 |
| ATE336230T1 (de) | 2006-09-15 |
| US20050186272A1 (en) | 2005-08-25 |
| DE602004001969T2 (de) | 2007-03-15 |
| JP2007523108A (ja) | 2007-08-16 |
| SI1566173T1 (sl) | 2006-12-31 |
| CA2554640C (fr) | 2011-04-12 |
| EP1566173A1 (fr) | 2005-08-24 |
| AU2005215108B2 (en) | 2010-10-07 |
| JP4800225B2 (ja) | 2011-10-26 |
| RU2006133543A (ru) | 2008-04-10 |
| EP1566173B1 (fr) | 2006-08-16 |
| PT1566173E (pt) | 2006-12-29 |
| DE602004001969D1 (de) | 2006-09-28 |
| ES2271714T3 (es) | 2007-04-16 |
| ZA200606554B (en) | 2008-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1109962T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας | |
| EE200300329A (et) | Meetod peroraalselt manustatavate epotiloonide biosaadavuse suurendamiseks ning selles kasutatav komplekt, ravimkoostis ja farmatseutiline ravimvorm | |
| EE200300373A (et) | Meetod kamptotetsiini analoogide sünteesimiseks kasutatavate ühendite valmistamiseks ning kamptotetsiini analoogide terviksüntees | |
| NO20090328L (no) | Nye forbindelser 385 | |
| NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
| CL2007001918A1 (es) | Compuestos derivados heteroarilos sustituidos; metodo para la preparacion de los compuestos; composicion farmaceutica; y uso para el tratamiento del dolor, depresion, enfermedad de alzheimer e hipertension entre otras. | |
| ATE337793T1 (de) | Dispergierbare pharmazeutische zusammensetzung eines entzündungshemmers | |
| MXPA04004464A (es) | Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades. | |
| NO20052010D0 (no) | Immunogen sammensetning | |
| NO20081844L (no) | Terapeutiske forbindelser | |
| NO20043367L (no) | Oralt farmasoytisk preparat | |
| CY1109366T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης | |
| DK1566173T3 (da) | Farmaceutisk sammensætning til oral anvendelse og fremgangsmåde til fremstilling deraf | |
| CY1112960T1 (el) | Παραγωγα ουριας, μεθοδοι για την παρασκευη τους και χρησεις αυτων | |
| DK1517890T3 (da) | Kationisk substituerede diphenylazetidinoner, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse | |
| NO20071299L (no) | Vedvarende frigivelse farmasoytisk sammensetning av tolterodine | |
| NO20054787D0 (no) | Indenderivater som farmasotiske midler | |
| MXPA05009686A (es) | Composicion farmaceutica comprendiendo acido 5-metil-2-(2'-cloro-6'-fluoroanilino) fenilacetico. | |
| ECSP066564A (es) | Formulaciones de tableta de liberación extendida de venlafaxina | |
| TW200640465A (en) | New pharmaceutically active compounds for the treatment of respiratory diseases | |
| SE0403118D0 (sv) | New compounds 2 | |
| SE0403117D0 (sv) | New compounds 1 | |
| ZA200706705B (en) | Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof | |
| CY1110814T1 (el) | Νεα υποκατεστημενα αρυλοεξαδιενικα οξεα και εστερες αυτων τα οποια μπορουν να χρησιμοποιηθουν για την αγωγη και προληψη του διαβητη, δυσλιπιδαιμιας και αθηροσκληρωσης, φαρμακευτικες συνθεσεις που τα περιλαμβανουν και διεργασιες για την παρασκευη αυτων | |
| DK1598366T3 (da) | Somatostatinanaloger |